Key points from article :
YouthBio Therapeutics develop tissue-specific partial reprogramming gene therapies to rejuvenate tissues, improve organ function, and prevent age-related diseases.
Developing organ-specific therapies that target age-related diseases such as Alzheimer's and wound healing.
Researching rejuvenating factors to enhance treatment safety by decoupling rejuvenation from cell identity changes.
Currently in the seed investment stage, raising $3.5 million for preclinical studies and platform development.
Identified rejuvenating factors, conducted safety study in mice for brain-specific therapy, and initiated studies in various disease models.
Founded the company based on belief in epigenetically driven aging process and potential of partial reprogramming therapy.
Ideal investor is someone who shares the mission and urgency to develop therapies for radical lifespan extension.
Personal longevity regime emphasizes mild exercise, sauna, sleep hygiene, moderate diet, and limited alcohol consumption.
